In the present study we characterized the structural and functional alterations in MAM and mitochondria and their effect on stress response mechanisms, in an in vitro model of AD, to support the role of MAM in AD and their potential as therapeutic targets in this disease. This evidence concerns the gene SGCG and Alzheimer disease.